
Expert Insight
MilliporeSigma Expands Protein A Portfolio to Tackle mAbs Challenges
MilliporeSigma is betting on advanced chromatography capabilities to address persistent bottlenecks in antibody manufacturing as the company prepares to integrate JSR Life Sciences’ Protein A resin technology into its bioprocessing portfolio. The acquisition, announced in October 2025 with an expected

